Mode
Text Size
Log in / Sign up
N/A N=214 Randomized Single-blind Treatment

Nurse-led Case Management for Diabetes and Cardiovascular Disease Patients With Depression

Depression

Enrolled (actual)
214
Serious AEs
1.4%
Results posted
May 2014
Primary outcome: Primary: Combined Effect of Intervention on SCL-20, Systolic Blood Pressure, LDL and HbA1c — -1.57 unitless — p=.001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Nurse-led case management (Behavioral); Treatment as usual (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Washington
Primary completion
Oct 2010

Outcome Measures

OutcomeResultp-value
PRIMARY
Combined Effect of Intervention on SCL-20, Systolic Blood Pressure, LDL and HbA1c
-1.57 .001 sig
PRIMARY
Symptom Checklist-20 Score at Baseline, 6 Months and 12 Months
1.65; 1.74; 1.26; 0.84; 1.14; 0.83 <0.001 sig
PRIMARY
Systolic Blood Pressure at Baseline, 6 Months and 12 Months
131.9; 135.7; 133.5; 131.9; 132.3; 131.0
PRIMARY
LDL Cholesterol at Baseline and 12 Months
109.4; 106.8; 101.4; 91.9
PRIMARY
Glycated Hemoglobin (HbA1c) at Baseline, 6 Months and 12 Months
8.04; 8.14; 7.87; 7.42; 7.81; 7.33
SECONDARY
Functional Impairment
4.2; 3.7; 4.5; 3.8 <0.01 sig
SECONDARY
Health Care Costs
21,513; 20,918

Summary

This study will evaluate the effectiveness of a nurse-led case management intervention in improving disease control and depression symptoms in adults with diabetes and/or heart disease who are also depressed.

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of diabetes and/or heart disease
  • Poor disease control (defined as an HbA1c level of at least 8.5%, blood pressure greater than 140/90 mm Hg, LDL cholesterol greater than 130 mg/dL)
  • Diagnosis of major depressive disorder

Exclusion Criteria

  • History of psychosis
  • At high risk for suicide
  • Cognitive impairment
  • Current alcohol or substance abuse disorder
  • Does not own a telephone
  • Currently seeking psychiatric care
  • Pregnant or breastfeeding
  • Currently enrolled in a Group Health Cooperative disease management program
  • Terminal illness
  • Plans to leave Group Health Cooperative in less than a year
  • Does not speak English
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00468676). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search